News

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
Thousands celebrate the rapid results of weight loss injections. But a new analysis reveals a harsh truth few are prepared ...
The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...